Welcome to our dedicated page for Dentsply Sirona news (Ticker: XRAY), a resource for investors and traders seeking the latest updates and insights on Dentsply Sirona stock.
Dentsply Sirona Inc. (Nasdaq: XRAY), a global innovator in dental technologies and oral health solutions, provides this dedicated news hub for stakeholders tracking its market activities. Access real-time updates on earnings reports, product launches, regulatory milestones, and strategic partnerships shaping the dental industry.
This resource consolidates official press releases and verified news to help investors and professionals stay informed about XRAY developments. Key updates include innovations in CAD/CAM systems, digital imaging advancements, and global distribution initiatives.
Bookmark this page for streamlined access to critical updates impacting dental practices and investment decisions. Regular visitors gain timely insights into how Dentsply Sirona maintains its leadership through technological excellence and operational execution.
Dentsply Sirona (Nasdaq: XRAY) announced preliminary results for Q2 2022, expecting net sales over $1,005 million and adjusted EPS at or above $0.60. Despite year-over-year sales decline due to foreign exchange impacts, organic sales grew, driven by strong demand in Europe and recent product launches. An ongoing internal investigation into financial matters may delay the filing of its quarterly report. The company has declared a quarterly dividend of $0.125 per share, payable on October 14, 2022. Nasdaq compliance issues are also addressed, with an extension granted for filing the required reports.
DENTSPLY SIRONA Inc. (Nasdaq: XRAY) announced a quarterly cash dividend of $0.125 per share, indicating an annual rate of $0.50. This dividend is scheduled for payment on July 8, 2022, to shareholders of record as of June 24, 2022. Dentsply Sirona is recognized as the world’s largest manufacturer of professional dental products, providing innovative solutions that enhance patient care. The company has a strong portfolio of products and brands, reinforcing its commitment to the dental industry.
Dentsply Sirona (Nasdaq: XRAY) received a notification from Nasdaq on May 12, 2022, indicating non-compliance with listing rules due to the failure to file its Quarterly Report on Form 10-Q for the period ended March 31, 2022. The Company has 60 days to address this deficiency or submit a compliance plan. This notice does not immediately affect the stock's listing, and the Company aims to file the missing report as soon as possible. An investigation regarding the accounting of sales incentives is ongoing, which may have contributed to the delay.
Dentsply Sirona (Nasdaq: XRAY) reported Q1 2022 net sales of $965 million, a decrease of 6.1% from $1,027 million in Q1 2021. EPS dropped to $0.30, down 43.8%, while adjusted EPS decreased to $0.52 from $0.72. Operating income fell 39.5% to $93 million. Despite these declines, operating cash flow improved to $93 million. The company updated its FY2022 outlook, projecting organic sales growth of 2% to 3% and adjusted EPS between $2.35 and $2.55. Challenges stemmed from macroeconomic headwinds and weaker U.S. performance.
Dentsply Sirona launched DS Core, a cloud-based platform enhancing digital dentistry, in collaboration with Google Cloud. The integrated system simplifies workflows, allows remote collaboration, and supports compliance with patient data regulations. Additionally, two new services, DS Core Create and DS Core Care, aim to optimize dental design and equipment support. The Primeprint Solution, an automated 3D printing system, was also introduced, promising efficiency and safety in dental practices. These innovations position Dentsply Sirona at the forefront of digital dentistry.
Dentsply Sirona (Nasdaq: XRAY) announced a revised date for its first quarter 2022 earnings conference call, now scheduled for May 10, 2022, at 8:30 am ET, moving from the previously set date of May 5. The call will be accessible via a live webcast on the Investors section of the company's website. A presentation related to the call will be published online, and a replay will be available for a week post-call. As the largest manufacturer of dental products, Dentsply Sirona continues to focus on innovation and effective solutions for patient care.
WellAir announced the appointment of Kari Dixon as President and CEO, effective immediately, succeeding Todd M. Pope, who will serve as Vice-Chair of the Board. Dixon, previously WellAir's CFO, possesses extensive experience in capital markets and financial planning, having worked with Dentsply Sirona and Form Technologies. Todd highlighted WellAir's advancements, including the launch of the FDA cleared Defend 400 air cleaning solution. Dixon aims to drive growth in the indoor air quality sector, emphasizing its significance in community wellness.
Dentsply Sirona has appointed John Groetelaars as Interim CEO following the termination of Don Casey. The Board is actively seeking a new CEO with a focus on driving operational excellence. Additionally, Barbara Bodem has been named Interim CFO to ensure a smooth transition after the departure of Jorge Gomez. Dentsply Sirona anticipates first quarter net sales of approximately $965 million, indicating a 1.4% decline year-over-year, affected by weaker U.S. sales and supply chain challenges. Further financial details will be disclosed on May 5, 2022.
Dentsply Sirona (Nasdaq: XRAY) has announced the resignation of Chief Financial Officer Jorge Gomez, effective May 6, 2022. Gomez, who joined the company in 2019, will take on a CFO role at another public company. The firm is now beginning the search for his replacement. CEO Don Casey expressed gratitude for Gomez’s contributions, notably in enhancing the Finance and IT sectors and improving the company's ESG initiatives. Dentsply Sirona maintains its status as the largest manufacturer of dental products and technologies worldwide.